The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Research Report 2025
Synopsis
The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. Isothermal amplification of nucleic acids is a simple process that rapidly and efficiently accumulates nucleic acid sequences at constant temperature.
The global Isothermal Nucleic Acid Amplification Technology (INAAT) market was valued at US$ 6277.8 million in 2023 and is anticipated to reach US$ 10880 million by 2030, witnessing a CAGR of 8.7% during the forecast period 2024-2030.
Global key players of Isothermal Nucleic Acid Amplification Technology (INAAT) include Abbott, BioMerieux and Hologic, etc. Global top three manufacturers hold a share over 70%. North America is the largest market of Isothermal Nucleic Acid Amplification Technology (INAAT), with a share nearly 80%, followed by Europe.
This report aims to provide a comprehensive presentation of the global market for Isothermal Nucleic Acid Amplification Technology (INAAT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isothermal Nucleic Acid Amplification Technology (INAAT).
Report Scope
The Isothermal Nucleic Acid Amplification Technology (INAAT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Isothermal Nucleic Acid Amplification Technology (INAAT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Isothermal Nucleic Acid Amplification Technology (INAAT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
BioMerieux
Hologic
BD
Grifols
Quidel
Meridian Bioscience
Qiagen
Eiken Chemical
OptiGene
HiberGene Diagnostic
Lucigen
Nippon Gene
Mast Group
New England Biolabs
Ustar Biotechnologies
Segment by Type
LAMP
TMA
NEAR
NASBA
HDA
SPIA
Other
Segment by Application
Medical Diagnostic
Scientific Research
Food Testing
Environmental Hygiene
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Isothermal Nucleic Acid Amplification Technology (INAAT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. Isothermal amplification of nucleic acids is a simple process that rapidly and efficiently accumulates nucleic acid sequences at constant temperature.
The global Isothermal Nucleic Acid Amplification Technology (INAAT) market was valued at US$ 6277.8 million in 2023 and is anticipated to reach US$ 10880 million by 2030, witnessing a CAGR of 8.7% during the forecast period 2024-2030.
Global key players of Isothermal Nucleic Acid Amplification Technology (INAAT) include Abbott, BioMerieux and Hologic, etc. Global top three manufacturers hold a share over 70%. North America is the largest market of Isothermal Nucleic Acid Amplification Technology (INAAT), with a share nearly 80%, followed by Europe.
This report aims to provide a comprehensive presentation of the global market for Isothermal Nucleic Acid Amplification Technology (INAAT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isothermal Nucleic Acid Amplification Technology (INAAT).
Report Scope
The Isothermal Nucleic Acid Amplification Technology (INAAT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Isothermal Nucleic Acid Amplification Technology (INAAT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Isothermal Nucleic Acid Amplification Technology (INAAT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
BioMerieux
Hologic
BD
Grifols
Quidel
Meridian Bioscience
Qiagen
Eiken Chemical
OptiGene
HiberGene Diagnostic
Lucigen
Nippon Gene
Mast Group
New England Biolabs
Ustar Biotechnologies
Segment by Type
LAMP
TMA
NEAR
NASBA
HDA
SPIA
Other
Segment by Application
Medical Diagnostic
Scientific Research
Food Testing
Environmental Hygiene
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Isothermal Nucleic Acid Amplification Technology (INAAT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 LAMP
1.2.3 TMA
1.2.4 NEAR
1.2.5 NASBA
1.2.6 HDA
1.2.7 SPIA
1.2.8 Other
1.3 Market by Application
1.3.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Diagnostic
1.3.3 Scientific Research
1.3.4 Food Testing
1.3.5 Environmental Hygiene
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Perspective (2019-2030)
2.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Growth Trends by Region
2.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Region (2019-2024)
2.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Region (2025-2030)
2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Dynamics
2.3.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Trends
2.3.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
2.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Challenges
2.3.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Revenue
3.1.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Revenue (2019-2024)
3.1.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Players (2019-2024)
3.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue
3.4 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio
3.4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue in 2023
3.5 Isothermal Nucleic Acid Amplification Technology (INAAT) Key Players Head office and Area Served
3.6 Key Players Isothermal Nucleic Acid Amplification Technology (INAAT) Product Solution and Service
3.7 Date of Enter into Isothermal Nucleic Acid Amplification Technology (INAAT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Type
4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Type (2019-2024)
4.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Type (2025-2030)
5 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Application
5.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Application (2019-2024)
5.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2019-2030)
6.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2019-2024)
6.4 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2019-2030)
7.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2019-2024)
7.4 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2019-2030)
8.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2019-2024)
8.4 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2019-2030)
9.2 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2019-2024)
9.4 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2019-2030)
10.2 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2019-2024)
10.4 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.1.4 Abbott Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 BioMerieux
11.2.1 BioMerieux Company Detail
11.2.2 BioMerieux Business Overview
11.2.3 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.2.4 BioMerieux Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.2.5 BioMerieux Recent Development
11.3 Hologic
11.3.1 Hologic Company Detail
11.3.2 Hologic Business Overview
11.3.3 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.3.4 Hologic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.3.5 Hologic Recent Development
11.4 BD
11.4.1 BD Company Detail
11.4.2 BD Business Overview
11.4.3 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.4.4 BD Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.4.5 BD Recent Development
11.5 Grifols
11.5.1 Grifols Company Detail
11.5.2 Grifols Business Overview
11.5.3 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.5.4 Grifols Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.5.5 Grifols Recent Development
11.6 Quidel
11.6.1 Quidel Company Detail
11.6.2 Quidel Business Overview
11.6.3 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.6.4 Quidel Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.6.5 Quidel Recent Development
11.7 Meridian Bioscience
11.7.1 Meridian Bioscience Company Detail
11.7.2 Meridian Bioscience Business Overview
11.7.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.7.4 Meridian Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.7.5 Meridian Bioscience Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Detail
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.8.4 Qiagen Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.8.5 Qiagen Recent Development
11.9 Eiken Chemical
11.9.1 Eiken Chemical Company Detail
11.9.2 Eiken Chemical Business Overview
11.9.3 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.9.4 Eiken Chemical Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.9.5 Eiken Chemical Recent Development
11.10 OptiGene
11.10.1 OptiGene Company Detail
11.10.2 OptiGene Business Overview
11.10.3 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.10.4 OptiGene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.10.5 OptiGene Recent Development
11.11 HiberGene Diagnostic
11.11.1 HiberGene Diagnostic Company Detail
11.11.2 HiberGene Diagnostic Business Overview
11.11.3 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.11.4 HiberGene Diagnostic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.11.5 HiberGene Diagnostic Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Detail
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.12.4 Lucigen Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.12.5 Lucigen Recent Development
11.13 Nippon Gene
11.13.1 Nippon Gene Company Detail
11.13.2 Nippon Gene Business Overview
11.13.3 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.13.4 Nippon Gene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.13.5 Nippon Gene Recent Development
11.14 Mast Group
11.14.1 Mast Group Company Detail
11.14.2 Mast Group Business Overview
11.14.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.14.4 Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.14.5 Mast Group Recent Development
11.15 New England Biolabs
11.15.1 New England Biolabs Company Detail
11.15.2 New England Biolabs Business Overview
11.15.3 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.15.4 New England Biolabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.15.5 New England Biolabs Recent Development
11.16 Ustar Biotechnologies
11.16.1 Ustar Biotechnologies Company Detail
11.16.2 Ustar Biotechnologies Business Overview
11.16.3 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.16.4 Ustar Biotechnologies Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2019-2024)
11.16.5 Ustar Biotechnologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
